NCT05320094 A Study to Evaluate the Effect of Activated Charcoal With Sorbitol on the Single-dose of Mavacamten in Healthy Participants Status COMPLETED Phase PHASE1
NCT05319093 Observational Study of the Effect of Ozanimod on Fatigue in Multiple Sclerosis Patients Status TERMINATED Phase N/A
NCT05308966 Observational Study in Patients With Previously Unresectable Malignant Pleural Mesothelioma Treated With Nivolumab and Ipilimumab (MESO-IMMUNE) Status COMPLETED Phase N/A
NCT05304533 A Study to Assess the Drug Interaction Between MYK-224 and Itraconazole and Verapamil in Healthy Participants Status COMPLETED Phase PHASE1
NCT05303220 A Study to Assess Relative Bioavailability of Branebrutinib, From a Tablet Formulation to the Capsule Formulation, the Effect of Food on the Bioavailability of Branebrutinib From a Tablet Formulation, and the Safety and Drug Levels of Branebrutinib From a Tablet Formulation in Healthy Participants Status COMPLETED Phase PHASE1
NCT05303051 Validation of the Diabetes Deep Neural Network Score for Diabetes Mellitus Screening Status WITHDRAWN Phase NA
NCT05302921 Neoadjuvant Dual Checkpoint Inhibition and Cryoablation in Relapsed/Refractory Pediatric Solid Tumors Status COMPLETED Phase PHASE2
NCT05301972 Expanded Access for Bromodomain and Extra-Terminal (BET) Inhibitor Status NO_LONGER_AVAILABLE Phase N/A
NCT05298592 A Study of BMS-986406 as Monotherapy and Combination Therapies in Participants With Advanced Tumors Status COMPLETED Phase PHASE1
NCT05297565 A Study to Compare Nivolumab Administered Subcutaneously vs Intravenous in Melanoma Participants Following Complete Resection Status COMPLETED Phase PHASE3
NCT05289492 Study of Novel Regimens in Relapsed or Refractory Multiple Myeloma Status TERMINATED Phase PHASE1
NCT05284890 A Study to Evaluate the Drug Levels of [14C]CC-99677 in Healthy Male Participants Status COMPLETED Phase PHASE1
NCT05282459 Enasidenib in MDS &Non-proliferative Chronic Myelomonocytic Leukemia w/o IDH2 Mutation Status COMPLETED Phase PHASE1/PHASE2
NCT05255601 A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of Relatlimab Plus Nivolumab in Pediatric and Young Adults With Hodgkin and Non-Hodgkin Lymphoma Status COMPLETED Phase PHASE1/PHASE2
NCT05250817 A Study of Preferences for the First-Line Treatment of Advanced/Metastatic Non-Small Cell Lung Cancer Status COMPLETED Phase N/A
NCT05245500 Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion Status RECRUITING Phase PHASE1
NCT05244070 A Study to Evaluate the Safety and Tolerability of BMS-986403 in Participants With Relapsed and/or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Status TERMINATED Phase PHASE1
NCT05236738 A Study to Compare the Drug Levels of Atazanavir and Cobicistat Between the Coadministration of Age-Appropriate Mini-Tablet Formulations and the Coadministration of the Individual Reference Products in Healthy Adults Under Fed Conditions Status COMPLETED Phase PHASE1
NCT05236608 A Study to Evaluate the Combination of Nivolumab With ADG106 in Metastatic NSCLC Status UNKNOWN Phase PHASE1/PHASE2